|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/553 | (2006.01) |
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3579840 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18704555.4 |
| Date of filing the European patent application | 2018-02-12 | |
| (97) | Date of publication of the European application | 2019-12-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/053457 |
| Date | 2018-02-12 |
| (87) | Number | WO 2018/146313 |
| Date | 2018-08-16 |
| (30) | Number | Date | Country code |
| PA201770091 | 2017-02-10 | DK |
| (72) |
FALTUM, Carsten , CH
JENSEN, Leif Helth , CH
DJAMGOZ, Mustafa , GB
|
| (73) |
Celex Oncology Innovations Limited ,
101 New Cavendish Street, London W1W 6XH,
GB
|
| (54) | TREATMENT OF CANCER AND INHIBITION OF METASTASIS |
| TREATMENT OF CANCER AND INHIBITION OF METASTASIS |